
DNO Awarded Operated Blocks in UK Offshore Licensing Round
Oslo, 30 October 2023 – DNO ASA, the Norwegian oil and gas operator, today announced that its wholly-owned subsidiary DNO North Sea (U.K.) Limited has been awarded a 50 percent operated interest in Blocks 9/9f, 9/10c, 9/14c and 9/15d in United Kingdom’s 33rd Offshore Licensing Round. Aker BP UK Limited will hold the remaining 50 percent in the licensed area.
The area is located adjacent to the Norwegian border and just west of the Aker BP operated Alvheim hub on the Norwegian Continental Shelf. The area also comprises the Agar discovery from 2018, in which the Company held a 25 percent interest until it was relinquished in 2020.
The technical work associated with the area will involve acquiring additional 3D seismic and potentially reprocessing the data to reduce risk and volume uncertainty. The first phase will have a duration of up to two years after which a decision on committing to a well will be made.
–
For further information, please contact:
Media: media@dno.no
Investors: investor.relations@dno.no
–
DNO ASA is a Norwegian oil and gas operator active in the Middle East, the North Sea and West Africa. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Côte d'Ivoire, Netherlands and Yemen.
This information is subject to the disclosure requirements pursuant to §5-12 of the Norwegian Securities Trading Act and the EU Market Abuse Regulation.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Prepayments (CK93) - Totalkredit A/S11.12.2023 10:05:00 CET | Press release
To the Nasdaq Copenhagen Prepayments (CK93) Pursuant to s 24 of the Danish Capital Markets Act, Totalkredit A/S hereby publishes prepayment data (CK93) as at 08 December 2023 in the attached file. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/. For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerely Totalkredit A/S Attachments Prepayments - Totalkredit A_S_11-12-2023eordindftk
Prepayments (CK93) - Nykredit Realkredit A/S11.12.2023 10:05:00 CET | Press release
To the Nasdaq Copenhagen Prepayments (CK93) Pursuant to s 24 of the Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes prepayment data (CK93) as at 08 December 2023 in the attached file. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/. For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerely Nykredit Realkredit A/S Attachments Prepayments - Nykredit Realkredit A_S_11-12-2023eordindf
Ekstraordinære indfrielser (CK93) - Totalkredit A/S11.12.2023 10:05:00 CET | pressemeddelelse
Til Nasdaq Copenhagen Ekstraordinære indfrielser (CK93) I medfør af kapitalmarkedsloven § 24 offentliggør Totalkredit A/S hermed oplysninger om ekstraordinære indfrielser (CK93) pr. den 8. december 2023 i vedhæftede fil. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Oplysningerne findes også i excel-format i Nykredits obligationsdatabase på https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/. For yderligere informationer om dataformat og -indhold henvises til Nasdaqs hjemmeside. Spørgsmål kan rettes til head of investor relations Morten Bækmand Nielsen på tlf. 44 55 15 21. Med venlig hilsen Totalkredit A/S Vedhæftede filer Ekstraordinære indfrielser - Totalkredit A_S_11-12-2023eordindftk
Ekstraordinære indfrielser (CK93) - Nykredit Realkredit A/S11.12.2023 10:05:00 CET | pressemeddelelse
Til Nasdaq Copenhagen Ekstraordinære indfrielser (CK93) I medfør af kapitalmarkedsloven § 24 offentliggør Nykredit Realkredit A/S hermed oplysninger om ekstraordinære indfrielser (CK93) pr. den 8. december 2023 i vedhæftede fil. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Oplysningerne findes også i excel-format i Nykredits obligationsdatabase på https://www.nykredit.com/en-gb/investor-relations/financial-reporting/prepayments/. For yderligere informationer om dataformat og -indhold henvises til Nasdaqs hjemmeside. Spørgsmål kan rettes til head of investor relations Morten Bækmand Nielsen på tlf. 44 55 15 21. Med venlig hilsen Nykredit Realkredit A/S Vedhæftede filer Ekstraordinære indfrielser - Nykredit Realkredit A_S_11-12-2023eordindf
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis11.12.2023 10:00:00 CET | Press release
London, Dec. 11, 2023 (GLOBE NEWSWIRE) -- London, UK – December 11, 2023 – OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is excited to announce a strategic collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions for systematic literature review and meta-analysis. Together, we aim to enhance the speed, efficiency, and depth of evidence synthesis, ultimately aiding biopharmaceutical researchers in making crucial healthcare decisions and bringing products to market quicker. “This collaboration underscores OPEN Health's unwavering commitment to leveraging innovative solutions and AI technologies for superior client delivery,” said Richard Jones, President of OPEN Health Evidence & Access. “We are excited to formalize our collaboration with Nested Knowledge and collectively bring market-leading evidence synthesis solutions to our clients.” Systemati